Takeda (TAK) CTO Lauren Duprey Rusckowski Sells 34,535 Shares

What Happened

• Lauren Duprey Rusckowski, Chief Transformation Officer at Takeda Pharmaceutical (TAK), sold 34,535 shares on 2026-09-14 at $18.54 per share, generating approximately $640,279 in proceeds. This was a sale (not a purchase or option exercise) reported on a Form 4.

Key Details

• Transaction date and price: 2026-09-14 at $18.54 per share.
• Shares sold: 34,535; total proceeds: ~$640,279.
• Transaction type: Sale (open-market or private sale, code S in filing).
• Filing date: 2026-09-15 — filed the day after the transaction (timely based on the provided dates).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other special footnotes indicated in the transaction details provided.

Context

• Sales by executives are common and may be routine (for diversification, tax, or personal-liquidity reasons); a single sale does not by itself indicate a change in the insider’s view of the company. This transaction was a straightforward sale, not an option exercise, grant, or gift.